NewsCAP: The USPSTF recommends tamoxifen, raloxifene, or aromatase inhibitors for women at high breast cancer risk.

NewsCAP: The USPSTF recommends tamoxifen, raloxifene, or aromatase inhibitors for women at high breast cancer risk.
Am J Nurs. 2019 Dec;119(12):15
Authors:
PMID: 31764039 [PubMed - in process]

Source: The American Journal of Nursing - November 27, 2019 Category: Nursing Tags: Am J Nurs Source Type: research